Eastman Chemical financials
$65.75−1.08%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8.75B | $9.38B | $9.21B | $10.58B | $10.48B | $8.47B | $9.27B | $10.15B | $9.55B | $9.01B |
| Gross profit | $1.84B | $2.29B | $2.06B | $2.14B | $2.50B | $1.98B | $2.23B | $2.48B | $2.36B | $2.36B |
| Gross margin | 21.1% | 24.4% | 22.4% | 20.2% | 23.9% | 23.3% | 24.1% | 24.4% | 24.7% | 26.2% |
| Operating income | $860.0M | $1.32B | $1.02B | $1.20B | $1.82B | $749.0M | $1.12B | $1.50B | $1.53B | $1.39B |
| Net income | $474.0M | $905.0M | $894.0M | $793.0M | $857.0M | $478.0M | $759.0M | $1.08B | $1.38B | $854.0M |
| Net margin | 5.4% | 9.6% | 9.7% | 7.5% | 8.2% | 5.6% | 8.2% | 10.6% | 14.5% | 9.5% |
| Diluted EPS | $4.10 | $7.67 | $7.49 | $6.35 | $6.25 | $3.50 | $5.48 | $7.56 | $9.47 | $5.75 |
| EBITDA | $1.47B | $1.89B | $1.55B | $1.73B | $2.40B | $1.55B | $1.86B | $2.15B | $2.13B | $2.01B |
| Operating cash flow | $970.0M | $1.29B | $1.37B | $975.0M | $1.62B | $1.46B | $1.50B | $1.54B | $1.66B | $1.39B |
| Free cash flow | $424.0M | $688.0M | $546.0M | $364.0M | $1.04B | $1.06B | $1.07B | $1.01B | $1.01B | $759.0M |
| Diluted shares | 115.6M | 117.9M | 119.4M | 124.9M | 137.1M | 136.5M | 138.5M | 142.9M | 146.1M | 148.4M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $566.0M | $837.0M | $548.0M | $493.0M | $459.0M | $564.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $4.79B | $5.02B | $4.85B | $5.15B | $5.16B | $5.62B |
| Total assets | $14.86B | $15.21B | $14.63B | $14.67B | $15.52B | $16.08B |
| Total liabilities | $8.82B | $9.36B | $9.10B | $9.43B | $9.73B | $9.97B |
| Shareholders' equity | $6.04B | $5.85B | $5.53B | $5.24B | $5.79B | $6.11B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology